Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.
| Last: | $47.98 |
|---|---|
| Change Percent: | 0.27% |
| Open: | $47.98 |
| Close: | $47.85 |
| High: | $48 |
| Low: | $47.98 |
| Volume: | 458,710 |
| Last Trade Date Time: | 10/27/2025 12:45:07 pm |
| Market Cap: | $1,232,715,019 |
|---|---|
| Float: | 15,877,822 |
| Insiders Ownership: | N/A |
| Institutions: | 136 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.talaristx.com |
| Country: | US |
| City: | New York |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Tourmaline Bio Inc. (NASDAQ: TRML).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
